WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Stock Ownership - Who owns Amicus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amicus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ellen RosenbergChief Legal Officer2025-11-2623,621$10.00
$236.21kSell
Ellen RosenbergChief Legal Officer2025-11-2623,621$5.13
$121.18kBuy
Ellen RosenbergChief Legal Officer2025-11-2536,000$5.13
$184.68kBuy
Ellen RosenbergChief Legal Officer2025-11-2536,000$10.00
$360.00kSell
Ellen RosenbergChief Legal Officer2025-11-2411,000$5.13
$56.43kBuy
David Michael ClarkChief People Officer2025-11-2425,643$10.10
$258.94kSell
Jeff CastelliChief Development Officer2025-11-2476,158$10.16
$773.69kSell
Jeff CastelliChief Development Officer2025-11-2450,000$9.03
$451.50kBuy
Ellen RosenbergChief Legal Officer2025-11-2425,000$6.10
$152.50kBuy
Bradley L. CampbellPresident and CEO2025-11-2414,587$9.03
$131.72kBuy

1 of 4

FOLD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FOLD insiders and whales buy or sell their stock.

FOLD Shareholders

What type of owners hold Amicus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC12.00%37,018,271$367.59MInsider
Vanguard Group Inc9.57%29,534,029$293.27MInstitution
Wellington Management Group LLP9.28%28,628,829$284.28MInstitution
Blackrock Inc8.38%25,848,965$256.68MInstitution
William Blair Investment Management LLC5.10%15,749,240$156.39MInstitution
Avoro Capital Advisors LLC4.87%15,025,000$149.20MInstitution
Redmile Group LLC4.18%12,890,146$128.00MInsider
Millennium Management LLC3.83%11,809,796$117.27MInstitution
State Street Corp3.75%11,562,939$114.82MInstitution
Charles W. Newhall Iii3.56%10,982,416$109.06MInsider

1 of 3

FOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FOLD65.99%34.01%Net SellingNet Selling
VRDN74.98%25.02%Net BuyingNet Buying
IDYA92.57%7.43%Net Buying
ADPT62.09%37.91%Net SellingNet Selling
DYN83.29%16.71%Net BuyingNet Selling
View Top Biotech Stocks

Amicus Therapeutics Stock Ownership FAQ

Who owns Amicus Therapeutics?

Amicus Therapeutics (NASDAQ: FOLD) is owned by 101.17% institutional shareholders, 52.15% Amicus Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Amicus Therapeutics shareholder, owning 37.02M shares representing 12.00% of the company. Perceptive Advisors LLC's Amicus Therapeutics shares are currently valued at $367.59M.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.